SCHEMBL5822376

SCHEMBL5822376

CCOC(=O)COc1ccc(C(=O)CN2C=C3C=CC(C(=N)NC(=O)OCC(C)C)C(=O)C3C2)cc1N(CC(=O)OCC)S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784627 0.90
SCHEMBL5786633 0.87 L3MBTL1 (0.34)
SCHEMBL5785045 0.86
SCHEMBL5783526 0.80 HRH3 (0.32)
SCHEMBL5782096 0.77 PDE4B (0.33)
SCHEMBL5780930 0.77 MAPT (0.32)
SCHEMBL2014790 0.77 AOC3 (0.32)
SCHEMBL5786080 0.77
SCHEMBL5785818 0.76 NPC1 (0.37)
SCHEMBL5785667 0.76 GAA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1677783-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE Nicholas Piramal India Limited (IN) 2006-07-12 EP disclosed
WO-2005035495-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE NICHOLAS PIRAMAL INDIA LIMITED (IN) 2005-04-21 WO disclosed